Neurocrine Biosciences (BSP:N1BI34) Change In Inventory : R$23 Mil (TTM As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Neurocrine Biosciences Change In Inventory?

Neurocrine Biosciences's change in inventory for the quarter that ended in Mar. 2024 was R$5 Mil. It means Neurocrine Biosciences's inventory declined by R$5 Mil from Dec. 2023 to Mar. 2024 .

Neurocrine Biosciences's change in inventory for the fiscal year that ended in Dec. 2023 was R$26 Mil. It means Neurocrine Biosciences's inventory declined by R$26 Mil from Dec. 2022 to Dec. 2023 .

Neurocrine Biosciences's Total Inventories for the quarter that ended in Mar. 2024 was R$185 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Neurocrine Biosciences's Days Inventory for the quarter that ended in Mar. 2024 was 455.54.

Inventory Turnover measures how fast the company turns over its inventory within a year. Neurocrine Biosciences's Inventory Turnover for the quarter that ended in Mar. 2024 was 0.20.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Neurocrine Biosciences's Inventory-to-Revenue for the quarter that ended in Mar. 2024 was 0.07.

Neurocrine Biosciences Change In Inventory Historical Data

The historical data trend for Neurocrine Biosciences's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurocrine Biosciences Change In Inventory Chart

Neurocrine Biosciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Inventory

Get a 7-Day Free Trial

-26.27

-55.05

-14.14

-13.64

26.46

Neurocrine Biosciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Inventory	Get a 7-Day Free Trial															9.38	7.77	14.32	-4.41	5.48

Neurocrine Biosciences Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was R$23 Mil.

Neurocrine Biosciences (BSP:N1BI34) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Neurocrine Biosciences's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	186.4555	/	37.349	*	365 / 4
	=	455.54

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Neurocrine Biosciences's Inventory Turnover for the quarter that ended in Mar. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	37.349	/	186.4555
	=	0.20

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Neurocrine Biosciences's Inventory to Revenue for the quarter that ended in Mar. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	186.4555	/	2566.091
	=	0.07

Neurocrine Biosciences Change In Inventory Related Terms

Thank you for viewing the detailed overview of Neurocrine Biosciences's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Neurocrine Biosciences (BSP:N1BI34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Neurocrine Biosciences Inc (BSP:N1BI34) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

NBIX:USA NB3:Germany

Address

12780 El Camino Real, San Diego, CA, USA, 92130

Website

https://www.neurocrine.com

Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome.

Neurocrine Biosciences (BSP:N1BI34) Headlines

No Headlines